DIVISLAB
Divis Laboratories Sell for TGT 2850RSI Divergence on Daily Chart
Window / Gap from Rs.2784 to Rs.3063
Considering Stock has closed around Rs.3050 for 2 consecutive day, any fall from hereon would cause the stock the to fall to Rs.2784 levels.
Suggestion: Sell a Call at CMP 3050 / 3000 with a SL Rs.3120.
Divislab - Short on break of 3000 | Don't short earlyThanks for coming to this update.
Before you start reading kindly hit that like button. It motivates me to keep doing such work for free.
Thanks
Looking at Divislab on the Daily time frame, we can see that it is testing out the 3000 area of support.
If 3000 breaks then, it can give a nice momentum to 2800. At 2800, it would be interesting to see which path it chooses next (whether Up or Down).
On the monthly, Divislab looks overextended and ripe for going short. We can even spot weakness as we can see wicks at the top.
Shorting Divislab below 3000 could be a good move.
Wait for 3000 to break and take a position accordingly as per your risk management.
Please note: These are my views and not trading advice. Please consult your financial adviser before making any trading decision.
“You create your own game in your mind based on your beliefs, intents, perception and rules.” ― Mark Douglas
divis labHello!! Divis lab is a good stock I feel it is in an uptrend but at a resistance, if it sustains over the resistance for a few daily candles it can see 400 pt.s up in abt. 1-4 months. but if it will come below the resistance then a retracement can be seen to the supports below. let's see what will happen tomorrow .....#my_view #learner
Trading Idea : Buy Divi's Laboratories Ltd.Stock is making higher top and higher bottom on daily chart. Stock has took support at 21 Day EMA and showing reversal from support. ADX is also giving positive cross over.
We are recommending Buy around 2330-2340 with Stop Loss of 2250 (Closing Basis) for Target of 2470 in next 8-10 Days.
Divis Laboratories Ltd Technical Analysis Indian Stocks Market Divis Laboratories Ltd Technical Analysis Indian Stocks Market
Divis Laboratories is engaged in the manufacture of Active Pharmaceutical ingredients (APIs), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the company, through its Custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.